Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)
Status:
Completed
Trial end date:
2015-04-27
Target enrollment:
Participant gender:
Summary
This is an efficacy and safety study of desloratadine (MK-4117) in Japanese participants with
seasonal allergic rhinitis (SAR). The primary hypothesis of this study is that the change
from Baseline in Total Nasal Symptom Score (TNSS) is improved by desloratadine compared to
placebo.